Identifying an early marker for congenital heart block: When is a long PR interval too long? Comment on the article by Sonesson et al. [7]

Arthritis and Rheumatism

Volumn 52, Issue 4, 2005, Pages 1341-1342

  Buyon, Jill P ^a   Askanase, Anca Dinu ^a   Kim, Mimi Y ^b   Copel, Joshua A ^c   Friedman, Deborah M ^d  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; LA ANTIBODY; MATERNAL ANTIBODY; RIBONUCLEOPROTEIN; RO ANTIBODY;

CONGENITAL HEART BLOCK; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; LETTER; PR INTERVAL; PRENATAL PERIOD; PRENATAL SCREENING; PRIORITY JOURNAL; SINUS RHYTHM; TIME;

ADULT; ANTIBODIES, ANTINUCLEAR; BIOLOGICAL MARKERS; FEMALE; FETAL DISEASES; HEART BLOCK; HEART CONDUCTION SYSTEM; HEART RATE, FETAL; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; ULTRASONOGRAPHY, PRENATAL;

EID: 17244375419     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20971     Document Type: Letter

References (12)

1. Waltuck J, Buyon J. Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994;120:544-51.
2. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
3. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block (CHB). Lupus 1995;4:116-21.
4. Sonesson SE, Salomonsson S, Jacobsson LA, Bremme K, Wahren-Herlenius M. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies. Arthritis Rheum 2004;50:1253-61.
5. Glickstein J, Buyon J, Kim M, Friedman D, and the PRIDE investigators. The fetal Doppler mechanical PR interval: a validation study. Fetal Diagn Ther 2004;19:31-4.
6. Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001;44:1832-5.
7. Solomon DG, Rupel A, Buyon JP. Birth order and recurrence rate in autoantibody-associated congenital heart block: implications for pathogenesis and family counseling. Lupus 2003;12:646-7.
8. Julkunen H, Kaaja R, Wallgren E, Teramo K. Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993;82:11-6.
9. Buyon JP, Winchester RJ, Slade SG, Arnett F, Copel J, Friedman D, et al. Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children: comparison of enzyme-linked immunosorbent assay and immunoblot to measure anti-SS-A/Ro and anti-SS-B/La antibodies. Arthritis Rheum 1993;36:1263-73.
10. Andelfinger G, Fouron JC, Sonesson SE, Proulx F. Reference values for time intervals between atrial and ventricular contractions of the fetal heart measured by two Doppler techniques. Am J Cardiol 2001;88:1433-6.
11. Van Hare GF, Dubin AM. The normal electrocardiogram. In: Allen HD, Clark EB, Gutgesell HP, Driscoll DJ, editors. Moss and Adams' heart disease in infants, children, and adolescents. 6th ed. New York: Lippincott Williams & Wilkins; 2001. p. 425-42.
12. Glickstein JS, Buyon JP, Friedman D. Pulsed Doppler echocardiographic assessment of the fetal PR interval. Am J Cardiol 2000;86:236-9.